Recent research provides robust evidence for the use of a digital visualization and decision support tool in colorectal (bowel) surgery. This is the first time that a digital decision support tool has ...

A clinical decision support tool that uses artificial intelligence (AI) to analyze scans after a stroke alongside treatment recommendations is associated with better quality care and long-term ...

Researchers at the University of Sheffield have developed a new patient-focused tool designed to better understand the lived experience of people wearing removable partial dentures. In their study ...

A meningitis vaccine does not protect against gonorrhea spread between men, a new clinical trial has concluded. Experts had hoped that a meningococcal B vaccine called 4CMenB might prevent the spread ...

Powerful brain imaging has helped uncover why people with post-traumatic stress disorder (PTSD) who engage in negative self-talk may be struggling with the first line of treatment. The discovery, ...

Having a primary care physician reduces emergency department (ED) use among patients with end-stage kidney disease receiving ...

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...

No matter the size or severity, wounds on human skin are difficult to monitor while they heal. Biopsies disrupt the wound site and are too invasive for routine, repeated monitoring, and most medical ...

Huntington's disease is a devastating brain disorder that slowly robs people of movement, memory, and personality. It is caused by a toxic protein that builds in brain cells and ultimately kills them.

A Finnish clinical imaging study shows that rest tremor in Parkinson's disease is not explained by greater dopamine loss. In ...

Applying artificial intelligence techniques to cardiac ultrasound data may make it easier to identify patients with advanced heart failure, a new study has found. The study—led by investigators at ...

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...